Skip to main content
SpringerLink
Log in

Nontuberculous Mycobacterial Infections

  • Chapter
  • First Online:
Bacterial Infections of Humans

  • 2893 Accesses

The nontuberculous mycobacteria (NTM) comprise over 125 different species that are widely distributed throughout the environment.(1) Over the decades the NTM have been referred to as mycobacteria other than tuberculosis (MOTT), atypical mycobacteria, and environmental mycobacteria. Despite their frequent isolation in the environment and human specimens, the NTM were not widely recognized as a cause of human disease until the late 1950 s. Since that time, the number of new species of NTM has grown dramatically primarily related to the availability of DNA sequencing, which has allowed identification of new species simply by detecting relatively small differences in DNA sequences. In addition to the proliferation of new species, the rate of disease related to NTM has also increased in some areas.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175(4):367–416.

    PubMed  CAS  Google Scholar 

  2. Marras TK, Daley CL. Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 2002;23:553–67.

    PubMed  Google Scholar 

  3. Branch A. Avian tubercle bacillus infection with special reference to mammals and to man: its reported association with Hodgkin’s disease. Arch Pathol 1931;12:253–74.

    Google Scholar 

  4. Griffith AS. Observation on the “M" strain of acid-fast bacilli. Tubercle 1933;15:53–9.

    Google Scholar 

  5. Branch A. A study of acid-fast organisms other than mammalian tubercle bacilli isolated from disease in man. Tubercle 1933;14: 337–53.

    Google Scholar 

  6. Lewis AG, Jr., Lasche EM, Armstrong AL, Dunbar FP. A clinical study of the chronic lung disease due to nonphotochromogenic acid-fast bacilli. Ann Intern Med 1960;53:273–85.

    PubMed  Google Scholar 

  7. Horsburgh CR, Jr., Selik RM. The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am Rev Respir Dis 1989:139(1):4–7.

    Google Scholar 

  8. Straus WL, Ostroff SM, Jernigan DB, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994;120(2):118–25.

    PubMed  CAS  Google Scholar 

  9. Carpenter JL, Parks JM. Mycobacterium kansasii infections in patients positive for human immunodeficiency virus. Rev Infect Dis 1991;13(5):789–96.

    PubMed  CAS  Google Scholar 

  10. Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med 1991;324:1332–8.

    PubMed  Google Scholar 

  11. Hawkins CC, Gold JW, Whimbey E, et al. Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1986;105(2):184–8.

    PubMed  CAS  Google Scholar 

  12. Kent PT, Kubica GP. A Guide for the Level III Laboratory: Public Health Mycobacteriology. Atlanta, GA: U.S. Department of Health and Human Services; 1985.

    Google Scholar 

  13. Heifets LB. Quantitative cultures and drug susceptibility testing of M. avium clinical isolates before and during the antimicrobial therapy (review). Res Microbiol 1994;145:188–96.

    PubMed  CAS  Google Scholar 

  14. Heifets LB, Jenkins PA. Speciation of mycobacteria in clinical laboratories. In: Gangadharam PRJ, Jenkins PA, eds. Mycobacteria, 1 – Basic Aspects. Philadelphia, PA: W.B. Saunders Company; 1998:308–50.

    Google Scholar 

  15. Rogall T, Flohr T, Bottger EC. Differentiation of Mycobacterium species by direct sequencing of amplified DNA. J Gen Microbiol 1990;136:1915–20.

    PubMed  CAS  Google Scholar 

  16. Butler WR, Jost KC, Kilburn JO. Identification of mycobacteria by high-performance liquid chromatography. J Clin Microbiol 1991;29:2468–72.

    PubMed  CAS  Google Scholar 

  17. Kirschner P, Springer B, Vogel U, et al. Genotypic identification of mycobacteria by nucleic acid sequence determination report of a two year experience in a clinical laboratory. J Clin Microbiol 1993;31:2882–9.

    PubMed  CAS  Google Scholar 

  18. Thibert L, Lapierre S. Routine application of high-performance liquid chromatography for identification of mycobacteria. J Clin Microbiol 1993;31:1759–63.

    PubMed  CAS  Google Scholar 

  19. Glickman SE, Kilburn SO, Butler WR. Rapid identification of mycolic acid patterns of mycobacteria by high-performance liquid chromatography using pattern recognition software and a Mycobacterium library. J Clin Microbiol 1994;32:740–9.

    PubMed  CAS  Google Scholar 

  20. Roberts GD, Bottger EC, Stockman L. Methods for the rapid identification of mycobacterial species. In: Heifets LB, ed. Clinical Mycobacteriology. Philadelphia, PA: W.B. Saunders Company; 1996:603–39.

    Google Scholar 

  21. El Amin NM, Hanson HS, Pettersson B, Petrini B, Von Stedink LV. 16S rRNA gene sequence analysis vs. conventional methods. Scand J Infect Dis 2000;32:47–50.

    CAS  Google Scholar 

  22. Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. . Clin Microbiol Rev 2001;14:704–26.

    PubMed  CAS  Google Scholar 

  23. Claud JL, Neal J, Rosenberry R, et al. Identification of Mycobacterium spp. by using a commercial 16S ribosomal DNA sequencing kit and additional sequencing libraries. J Clin Microbiol 2002;40:400–6.

    Google Scholar 

  24. Hall L, Doerr KA, Wohlfiel SL, Roberts GD. Evaluation of the MicroSeq system for identification of mycobacteria by 16S ribosomal DNA sequencing and its integration into a routine clinical mycobacteriology laboratory. J Clin Microbiol 2003;41: 1447–53.

    PubMed  CAS  Google Scholar 

  25. Jost KC, Jr., Dunbar DF, Barth SS, Headley VL, Elliot LB. Identification of Mycobacterium tuberculosis and M. avium complex directly from smear-positive sputum specimens and Bactec 12B cultures by high-performance liquid chromatography with fluorescence detection and computer-driven pattern recognition models. J Clin Microbiol 1995;33:1270–7.

    PubMed  Google Scholar 

  26. Kitada S, Maekura R, Toyoshima N, et al. Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Clin Infect Dis 2002;35(11):1328–35.

    PubMed  Google Scholar 

  27. Kitada S, Kobayashi K, Ichiyama S, et al. Serodiagnosis of Mycobacterium avium complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med 2007.

    Google Scholar 

  28. Mazurek GH, LoBue PA, Daley CL, et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. Jama 2001;286(14):1740–7.

    PubMed  CAS  Google Scholar 

  29. Shah SS, McGowan JP, Klevin RS, Converse PJ, Blum S, Gourevitch MN. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users. Med Sci Monit 2006; 12(4):MT11–6.

    Google Scholar 

  30. Goodfellow M, Magee JG. Taxonomy of mycobacteria. In: Gangadharam PRJ, Jenkins PA, eds. Mycobacteria I – Basic Aspects. New York: Chapman and Hall (International Thomson Publishing); 1998:1–71.

    Google Scholar 

  31. Goodfellow M, Wayne LG. Taxonomy and nomenclature. In: Ratledge C, Stanford J, eds. The Biology of the Mycobacteria. London: Academic Press, Inc., Ltd.; 1982:471–521.

    Google Scholar 

  32. Tortoli E. Impact of genotypic studies on mycobacterial taxonomy: the new mycobacteria of the 1990’s. Clin Microbiol Rev 2003;16:319–54.

    PubMed  CAS  Google Scholar 

  33. Tortoli E. The new mycobacteria: an update. FEMS Immunol Med Microbiol 2006;48:159–78.

    CAS  Google Scholar 

  34. Heifets L. Mycobacterial infections caused by nontuberculous mycobacteria. Sem Respir Crit Care Med 2004;25:283–95.

    Google Scholar 

  35. Palmer CE. Tuberculin sensitivity and contact with tuberculosis; further evidence of nonspecific sensitivity. Am Rev Tuberc 1953;68(5):678–94.

    PubMed  CAS  Google Scholar 

  36. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969;99:1–131.

    PubMed  Google Scholar 

  37. O’Brien RJ, Geiter LJ, Snider DE. The epidemiology of nontuberculous mycobacterial diseases in the United States: results from a national survey. Am Rev Respir Dis 1987;135:1007–14.

    PubMed  Google Scholar 

  38. Butler WR, Crawford JT. Nontuberculous mycobacteria reported to the public health laboratory information system by state public health laboratories United States 1993–1996. 1999 (Accessed at http://www.cdc.gov/ncidod/dastlr/mycobacteriology.htm)

  39. Dailloux M, Abalain ML, Laurain C, et al. Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 2006;28(6):1211–5.

    PubMed  CAS  Google Scholar 

  40. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario 1997–2003. Thorax 2007;62:661–6.

    PubMed  Google Scholar 

  41. Reed C, von Reyn CF, Chamblee S, et al. Environmental risk factors for infection with Mycobacterium avium complex. Am J Epidemiol 2006;164(1):32–40.

    PubMed  Google Scholar 

  42. Khan K, Wang J, Marras TK. Nontuberculous Mycobacterial Sensitization in the United States: National Trends Over Three Decades. Am J Respir Crit Care Med 2007.

    Google Scholar 

  43. Hadjiliadis D, Adlakha A, Prakash UB. Rapidly growing mycobacterial lung infection in association with esophageal disorders. Mayo Clin Proc 1999;74(1):45–51.

    PubMed  CAS  Google Scholar 

  44. Oliver A, Maiz L, Canton R, Escobar H, Baquero F, Gomez-Mampaso E. Nontuberculous mycobacteria in patients with cystic fibrosis. Clin Infect Dis 2001;32:1298–303.

    PubMed  CAS  Google Scholar 

  45. Olivier KN, Weber DJ, Wallace RJ, Jr., et al. Nontuberculous mycobacteria in cystic fibrosis study group. Nontuberculous mycobacteria. I: Multicenter prevalence study in cystic fibrosis. Am J Respir Crit Care Med 2003;167:828–34.

    PubMed  Google Scholar 

  46. Good RC, Snider DE, Jr. Isolation of nontuberculous mycobacteria in the United States, 1980. J Infect Dis 1982;146:829–33.

    PubMed  CAS  Google Scholar 

  47. Witty LA, Tapson VF, Piantadosi CA. Isolation of mycobacteria in patients with pulmonary alveolar proteinosis. Medicine 1994;73(2):103–9.

    PubMed  CAS  Google Scholar 

  48. Ziedalski TM, Kao PN, Henig NR, Jacobs SS, Ruoss SJ. Prospective analysis of cystic fibrosis transmembrane regulator mutations in adults with bronchiectasis or pulmonary nontuberculous mycobacterial infection. Chest 2006;130(4):995–1002.

    PubMed  Google Scholar 

  49. Kaminska AM, Huitt GA, Fulton KE, Worthen GS, Iseman MD, Chan ED. Prevalence of alpha-1-antitrypsin (AAT) mutations in 100 bronchiectatic patients with rapid-growing mycobacterial (RGM) infections. Am J Respir Crit Care Med 2003;167:A708.

    Google Scholar 

  50. Kim JS, Tanaka N, Newell JD, et al. Nontuberculous mycobacterial infection: CT scan findings, genotype, and treatment responsiveness. Chest 2005;128(6):3863–9.

    PubMed  Google Scholar 

  51. Fowler SJ, French J, Screaton NJ, et al. Nontuberculous mycobacteria in bronchiectasis: Prevalence and patient characteristics. Eur Respir J 2006;28(6):1204–10.

    PubMed  CAS  Google Scholar 

  52. Chan ED, Kaminska AM, Gill W, et al. Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages. Scand J Infect Dis 2007;39(8): 690–6.

    CAS  Google Scholar 

  53. Corbett EL, Blumberg L, Churchyard GJ, et al. Nontuberculous mycobacteria: defining disease in a prospective cohort of South African miners. Am J Respir Crit Care Med 1999;160: 15–21.

    PubMed  CAS  Google Scholar 

  54. Casanova JL, Abel L. Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002;20:581–620.

    PubMed  CAS  Google Scholar 

  55. Dorman SE, Holland SM. Interferon-gamma and interleukin-12 pathway defects and human disease. Cytokine Growth Factor Rev 2000;11:321–33.

    PubMed  CAS  Google Scholar 

  56. Iseman MD, Buschman DL, Ackerson LM. Pectus excavatum and scoliosis. Thoracic anomalies associated with pulmonary disease caused by Mycobacterium avium complex. Am Rev Respir Dis 1991;144:914–6.

    PubMed  CAS  Google Scholar 

  57. Crow HE, Corpe RF, SMith CE. Is serious pulmonary disease caused by nonphotochromogenic (“atypical") acid-fast mycobacteria communicable?. Dis Chest 1961;39:372–81.

    PubMed  CAS  Google Scholar 

  58. Gruft H, Falkinham JOI, Parker BC. Recent experience in the epidemiology of disease caused by atypical mycobacteria. Rev Infect Dis 1981;3:990–6.

    PubMed  CAS  Google Scholar 

  59. Chapman JS. The ecology of the atypical mycobacteria. Arch Environ Health 1971;22:41–6.

    PubMed  CAS  Google Scholar 

  60. Sniezak PJ, Graham BS, Busch HB, et al. Rapidly growing mycobacterium infections following pedicures. Arch Dermatol 2003;139: 629–34.

    Google Scholar 

  61. Gira AK, Reisenauer H, Hammock L, et al. Furunculosis due to Mycobacterium mageritense associated with footbaths at a nail salon. J Clin Microbiol 2004;42:1813–7.

    PubMed  Google Scholar 

  62. Winthrop KL, Abrams M, Yakrus MA, et al. An outbreak of Mycobacterial furunculosis associated with footbaths at a nail salon. N Engl J Med 2002;346:1366–71.

    PubMed  Google Scholar 

  63. Conger NG, O’Connell RJ, Laurel VL, et al. Mycobacterium simiae outbreak associated with a hospital water supply. Infect Control Hosp Epidemiol 2004;25:1050–5.

    PubMed  Google Scholar 

  64. Gubler JG, Salfinger HM, von Graevenitz A. Pseudoepidemic of nontuberculous mycobacteria due to a contaminated bronchoscope clearing machine: report of an outbreak and review of the literature. Chest 1992;101:1245–9.

    PubMed  CAS  Google Scholar 

  65. El Sahly HM, Septimus E, Soini H, et al. Mycobacterium simiae pseudo-outbreak resulting from a contaminated hospital water supply in Houston, Texas. Clin Infect Dis 2002;35:802–7.

    PubMed  Google Scholar 

  66. Robakiewicz M, Grzybowski S. Epidemiological aspects of non-tuberculous mycobacterial disease and of tuberculosis in British Columbia. Am Rev Respir Dis 1974;109:613–20.

    Google Scholar 

  67. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis 1979;110:107–59.

    Google Scholar 

  68. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA. A demographic study of disease due to Mycobacterium kansasii or Mycobacterium intracellulare-avium in Texas. Chest 1979;75:120–5.

    PubMed  CAS  Google Scholar 

  69. Griffith DE, Girard WM, Wallace RJ, Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. Am Rev Respir Dis 1993;147:1271–8.

    PubMed  CAS  Google Scholar 

  70. Bange FC, Brown BA, Smaczny C, Wallace RJ, Jr., Bottger EC. Lack of transmission of Mycobacterium abscessus among patients with cystic fibrosis attending a single clinic. Clin Infect Dis 2001;32:1648–50.

    PubMed  CAS  Google Scholar 

  71. Sermet-Gaudelus I, Le Bourgeois M, Pierre-Audiger C, et al. Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis 2003;9:1587–91.

    PubMed  Google Scholar 

  72. Marras TK, Wallace RJ, Jr., Koth LL, Stulbarg MS. Hypersensitivity pneumonitis reaction to Mycobacterium avium in household water. Chest 2005;127:664–71.

    PubMed  Google Scholar 

  73. De Groote MA, Pace NR, Fulton K, Falkinham JO, 3rd. Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils. Appl Environ Microbiol 2006;72(12):7602–6.

    PubMed  Google Scholar 

  74. Falkinham JO. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529–51.

    PubMed  Google Scholar 

  75. Nishiuchi Y, Maekura R, Kitada S, et al. The recovery of Mycobacterium avium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC. Clin Infect Dis 2007;45(3):347–51.

    PubMed  CAS  Google Scholar 

  76. Carson LA, Bland LA, Cusick LB, et al. Prevalence of nontuberculous mycobacteria in water supplies of hemodialysis centers. Appl Environ Microbiol 1988;54(12):3122–5.

    PubMed  CAS  Google Scholar 

  77. Schulze-Robbecke R, Janning B, Fischeder R. Occurrence of mycobacteria in biofilm samples. Tuber Lung Dis 1992;73: 141–4.

    PubMed  CAS  Google Scholar 

  78. Tobin-D’Angelo MJ, Blass MA, del Rio C, Halvosa JS, Blumberg HM, Horsburgh CR Jr. Hospital water as a source of Mycobacterium avium complex isolates in respiratory specimens. J infect Dis. 2004;189(1):98–104.

    Google Scholar 

  79. Dorman SE, Picard C, Lammas D, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004;364(9451):2113–21.

    PubMed  CAS  Google Scholar 

  80. Tanaka E, Kimoto T, Matsumoto H, et al. Familial pulmonary Mycobacterium avium complex disease. Am J Respir Crit Care Med 2000;161:1643–7.

    PubMed  CAS  Google Scholar 

  81. Ahn CH, McLarty JW, Ahn SS, Ahn SI, Hurst GA. Diagnostic criteria for pulmonary disease caused by Mycobacterium kansasii and Mycobacterium intracellulare. Am Rev Respir Dis 1982;125: 388–91.

    PubMed  CAS  Google Scholar 

  82. Prince DS, Peterson DD, Steiner RM, et al. Infection with Mycobacterium avium complex in patients without predisposing conditions [see comments]. N Engl J Med 1989;321:863.

    PubMed  CAS  Google Scholar 

  83. Erasmus JJ, McAdams HP, Farrell MA, Patz EF, Jr. Pulmonary nontuberculous mycobacterial infection: radiologic manifestations. Radiographics 1999;19(6):1487–505.

    PubMed  CAS  Google Scholar 

  84. Liao CH, Lai CC, Ding LW, et al. Skin and soft tissue infection caused by non-tuberculous mycobacteria. Int J Tuberc Lung Dis 2007;11(1):96–102.

    CAS  Google Scholar 

  85. Bartralot R, Garcia-Patos V, Sitjas D, et al. Clinical patterns of cutaneous nontuberculous mycobacterial infections. Br J Dermatol 2005;152(4):727–34.

    CAS  Google Scholar 

  86. Wallace RJ, Jr., Cook JL, Glassroth J, Griffith DE, Olivier KN, Gordin F. American Thoracic Society Statement: Diagnosis and treatment of disease caused by nontuberculous mycobacteria. Am J Respir Crit Care Med 1997;156:S1–S25.

    Google Scholar 

  87. Tsukamura M. Diagnosis of disease caused by Mycobacterium avium complex. Chest 1991;99(3):667–9.

    PubMed  CAS  Google Scholar 

  88. Blackwell V. Mycobacterium marinum infections. Curr Opin Infect Dis 1999;12(3):181–4.

    PubMed  CAS  Google Scholar 

  89. Edelstein H. Mycobacterium marinum skin infections. Report of 31 cases and review of the literature. Arch Intern Med 1994; 154(12):1359–64.

    PubMed  CAS  Google Scholar 

  90. Wallace RJ, Jr., Brown BA, Griffith DE, Girard WM, Murphy DT. Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. Am J Respir Crit Care Med 1996;153: 1766–72.

    PubMed  Google Scholar 

  91. Griffith DE, Brown BA, Girard WM, Griffith BE, Couch LA, Wallace RJ, Jr. Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease. Clin Infect Dis 2001;32: 1547–53.

    PubMed  CAS  Google Scholar 

  92. Tanaka E, Kimoto T, Tsuyuguchi K, et al. Effect of clarithromycin regimen for Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med 1999;160:866–72.

    PubMed  CAS  Google Scholar 

  93. Kobashi Y, Matsushima T. The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. Intern Med (Tokyo, Japan) 2003;42(8): 670–5.

    CAS  Google Scholar 

  94. Griffith DE, Brown BA, Cegielski P, Murphy DT, Wallace RJ, Jr. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Clin Infect Dis 2000;302:288–92.

    Google Scholar 

  95. Lam PK, Griffith DE, Aksamit TR, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2006;173(11):1283–9.

    PubMed  CAS  Google Scholar 

  96. Kobashi Y, Matsushima T, Oka M. A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease. Respir Med 2007;101(1):130–8.

    PubMed  Google Scholar 

  97. Griffith DE, Brown-Elliott BA, Shepherd S, McLarty J, Griffith L, Wallace RJ, Jr. Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2005;172(2):250–3.

    PubMed  Google Scholar 

  98. Nelson KG, Griffith DE, Brown BA, Wallace RJ, Jr. Results of operation in Mycobacterium avium-intracellulare lung disease. Ann Thorac Surg 1998;66:325–30.

    PubMed  CAS  Google Scholar 

  99. Pomerantz ML, Madsen L, Goble M, Iseman MD. Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections. Ann Thorac Surg 1991;52:1108–12.

    PubMed  CAS  Google Scholar 

  100. Shiraishi Y, Nakajima Y, Takasuna K, Hanaoka T, Katsuragi N, Konno H. Surgery for Mycobacterium avium complex lung disease in the clarithromycin era. Eur J Cardiothorac Surg 2002;21: 314–8.

    PubMed  Google Scholar 

  101. Shiraishi Y, Fukushima K, Komatsu H, Kurashima A. Early pulmonary resection for localized Mycobacterium avium complex disease. Ann Thorac Surg 1998;66:183–6.

    PubMed  CAS  Google Scholar 

  102. Pomerantz ML, Denton JR, Huitt GA, Brown JM, Powell LA, Iseman MD. Resection of the right middle lobe and lingula for mycobacterial infection. Ann Thorac Surg 1996;62:990–3.

    PubMed  CAS  Google Scholar 

  103. Pezzia W, Raleigh JW, Bailey MC, Toth EA, Silverhlatt J. Treatment of pulmonary disease due to Mycobacterium kansasii: recent experience with rifampin. Rev Infect Dis 1981;3:1035–9.

    PubMed  CAS  Google Scholar 

  104. Ahn CH, Lowell JR, Ahn SA, Ahn S, Hurst GA. Chemotherapy for pulmonary disease due to Mycobacterium kansasii: efficacies of some individual drugs. Rev Infect Dis 1981;3:1028–34.

    PubMed  CAS  Google Scholar 

  105. Ahn CH, Lowell JR, Ahn SS, Ahn SI, Hurst GA. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii. Am Rev Respir Dis 1983;128:1048–50.

    PubMed  CAS  Google Scholar 

  106. Griffith DE, Brown-Elliot BA, Wallace RJ, Jr. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. Clin Infect Dis 2003;37:1178–82.

    PubMed  CAS  Google Scholar 

  107. Research Committee of the British Thoracic Society. First randomized trial of treatments for pulmonary disease caused by Mycobacterium avium intracellulare, Mycobacterium malmoense, and Mycobacterium xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax 2001;56:167–72.

    Google Scholar 

  108. Kaplan JE, Masur H, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons. MMWR Morb Mortal Wkly Rep 2002;#RR-8:1–52.

    Google Scholar 

  109. Oldfield EC, 3rd, Fessel WJ, Dunne MW, et al. Once weekly azithromycin therapy for prevention of Mycobacterium avium complex infection in patients with AIDS: a randomized, double-blind, placebo-controlled multicenter trial. Clin Infect Dis 1998;26: 611–9.

    PubMed  Google Scholar 

  110. El-Sadr WM, Burman WJ, Grant LB, et al. Discontinuation of prophylaxis against Mycobacterium avium complex disease in HIV-infected patients who have a response to antiretroviral therapy. N Engl J Med 2000;342:1085–92.

    PubMed  CAS  Google Scholar 

  111. Wickman K. Clinical significance of nontuberculous mycobacteria. A bacteriological survey of Swedish strains isolated between 1973 and 1981. Scand J Infect Dis 1986;18(4):337–45.

    PubMed  CAS  Google Scholar 

  112. Romanus V, Hallander HH, Wahlen P, Olinder-Nielsen AM, Magnusson PHW, Juhlin I. Atypical mycobacteria in extrapulmonary disease among children. Incidence in Sweden from 1969 to 1990, related to changing BCG-vaccination coverage. Tuber Lung Dis 1995;76:300–10.

    PubMed  CAS  Google Scholar 

  113. Trnka L, Dankova D, Svandova E. Six years’ experience with the discontinuation of BCG vaccination. 4. Protective effect of BCG vaccination against the Mycobacterium avium intracellulare complex. Tuber Lung Dis 1994;75(5):348–52.

    PubMed  CAS  Google Scholar 

  114. Woods GL, Washington JA. Mycobacteria other than Mycobacterium tuberculosis: review of microbiologic and clinical aspects. Rev Infect Dis 1987;9:275–94.

    PubMed  CAS  Google Scholar 

Suggested Reading

  • Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco MF, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ, Jr., Winthrop K. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367–416.

    PubMed  CAS  Google Scholar 

  • Clinics in Chest Medicine. Lung Disease Due to Nontuberculous Mycobacterial Infections. Eds Antonino Catanzaro and Charles L. Daley. September 2002. W. B. Saunders Company, Philadelphia, PA.

    Google Scholar 

  • Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997–2003. Thorax 2007;62:661–666.

    PubMed  Google Scholar 

  • Field SK, Cowie RL. Lung disease due to the more common nontuberculous mycobacteria. Chest 2006;129:1653–1672.

    PubMed  Google Scholar 

  • Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest 2004;126:566–581.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Mycobacterial and Respiratory Infections, National Jewish Medical and Research Center and the University of Colorado Health Sciences Center Head, Denver, Colorado 80206, USA

    Charles L. Daley

Authors
  1. Charles L. Daley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles L. Daley .

Editor information

Editors and Affiliations

  1. Rollins School of Public Health, Emory University, Clifton Road NE., 1518, Atlanta, 30322, U.S.A.

    Philip S. Brachman

  2. College of Medicine, Office of Faculty Affairs, Drexel University, Race Street 1505, Philadelphia, 19102, U.S.A.

    Elias Abrutyn

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Daley, C.L. (2009). Nontuberculous Mycobacterial Infections. In: Brachman, P., Abrutyn, E. (eds) Bacterial Infections of Humans. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-09843-2_41

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-09843-2_41

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-09842-5

  • Online ISBN: 978-0-387-09843-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation